Familial renal glucosuria:: SLC5A2 mutation analysis and evidence of salt-wasting

被引:74
作者
Calado, J
Loeffler, J
Sakallioglu, O
Gok, F
Lhotta, K
Barata, J
Rueff, J
机构
[1] Univ Nova Lisboa, Inst Higiene & Med Trop, Fac Ciencias Med, Dept Genet, P-1349008 Lisbon, Portugal
[2] Innsbruck Med Univ, Div Nephrol, Innsbruck, Austria
[3] GATA Med Fac, Div Pediat Nephrol, Ankara, Turkey
[4] Hosp Santa Cruz, Dept Nephrol, Lisbon, Portugal
关键词
glucosuria; renal; SLC5A2; SGLT2; mutation;
D O I
10.1038/sj.ki.5000194
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Familial renal glucosuria ( FRG) is an inherited renal tubular disorder characterized by persistent isolated glucosuria in the absence of hyperglycemia. Mutations in the sodium/glucose co-transporter SGLT2 coding gene, SLC5A2, were recently found to be responsible for the disorder. Here, we report the molecular and phenotype study of five unrelated FRG families. Five patients were identified and their family members screened for glucosuria. SLC5A2 coding region of index cases was polymerase chain reaction amplified and sequenced. Five different mutations are reported, including four novel alleles. The IVS12+1G>A and p.A102V alleles were identified in homozygosity in index patients of two unrelated families. A proband from another family was compound heterozygous for the p.R132H and p.A219T mutations, and the heterozygous p.Q167fsX186 frameshift allele was the only mutation detected in the affected individual from an additional pedigree. For the remaining family no mutations were detected. The patient homozygous for the p.A102V mutation had glucosuria of 65.6 g/1.73 m(2)/ 24 h, evidence of renal sodium wasting, mild volume depletion, and raised basal plasma renin and serum aldosterone levels. Our findings confirm previous observations that in FRG, transmitted as a codominant trait with incomplete penetrance, most mutations are private. In the only patient with massive glucosuria in our cohort there was evidence evocative of renin - angiotensin aldosterone system activation by extracellular volume depletion induced by natriuresis. Definite proof of renin - angiotensin aldosterone system activation in FGR should rely on evaluation of additional patients with massive glucosuria.
引用
收藏
页码:852 / 855
页数:4
相关论文
共 18 条
  • [1] Novel compound heterozygous mutations in SLC5A2 are responsible for autosomal recessive renal glucosuria
    Calado, J
    Soto, K
    Clemente, C
    Correia, P
    Rueff, J
    [J]. HUMAN GENETICS, 2004, 114 (03) : 314 - 316
  • [2] A novel SGLT2 mutation in a patient with autosomal recessive renal glucosuria
    Francis, J
    Zhang, JH
    Farhi, A
    Carey, H
    Geller, DS
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) : 2893 - 2895
  • [3] THE HUMAN KIDNEY LOW-AFFINITY NA+/GLUCOSE COTRANSPORTER SGLT2 - DELINEATION OF THE MAJOR RENAL REABSORPTIVE MECHANISM FOR D-GLUCOSE
    KANAI, Y
    LEE, WS
    YOU, GF
    BROWN, D
    HEDIGER, MA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) : 397 - 404
  • [4] A missense mutation in the Na+/glucose cotransporter gene SGLT1 in a patient with congenital glucose-galactose malabsorption:: normal trafficking but inactivation of the mutant protein
    Kasahara, M
    Maeda, M
    Hayashi, S
    Mori, Y
    Abe, T
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2001, 1536 (2-3): : 141 - 147
  • [5] Renal glucosuria due to SGLT2 mutations
    Kleta, R
    Stuart, C
    Gill, FA
    Gahl, WA
    [J]. MOLECULAR GENETICS AND METABOLISM, 2004, 82 (01) : 56 - 58
  • [6] MACKENZIE B, 1994, J BIOL CHEM, V269, P22488
  • [7] A novel missense mutation in SLC5A2 encoding SGLT2 underlies autosomal-recessive renal glucosuria and aminoaciduria
    Magen, D
    Sprecher, E
    Zelikovic, I
    Skorecki, K
    [J]. KIDNEY INTERNATIONAL, 2005, 67 (01) : 34 - 41
  • [8] PAJOR AM, 1992, J BIOL CHEM, V267, P3557
  • [9] Santer R., 2000, Journal of Inherited Metabolic Disease, V23, P178
  • [10] Molecular analysis of the SGLT2 gene in patients with renal glucosuria
    Santer, R
    Kinner, M
    Lassen, CL
    Schneppenheim, R
    Eggert, P
    Bald, M
    Brodehl, J
    Daschner, M
    Ehrich, JHH
    Kemper, M
    Volti, SL
    Neuhaus, T
    Skovby, F
    Swift, PGF
    Schaub, J
    Klaerke, D
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (11): : 2873 - 2882